LUGANO, Switzerland & OSAKA, Japan--(BUSINESS WIRE)--Healiva SA (Healiva) and C4U Corporation (C4U) are pleased to announce that they have entered into a strategic alliance agreement regarding the ...

With further optimization and safety evaluation, this CRISPR–Cas3 can be established as a new and safer platform for genome-editing-based therapies, providing patients with durable, possibly one-time ...

The last time The Lancet Microbe featured an Editorial on CRISPR was in November 2020, to mark that year’s Nobel Prize in Chemistry, jointly awarded to Emmanuelle Charpentier and Jennifer A Doudna for ...

In a new study, the researchers have shown that the CRISPR–Cas3 system can induce reliable, extensive deletions of the transthyretin (TTR) gene and reduce production of TTR protein without any ...

CRISPR gene editing has transitioned from a laboratory curiosity to a cornerstone of modern biotechnology, revolutionizing our approach to genetic diseases, including Charcot-Marie-Tooth (CMT) disease ...